Genetic testing company 23andMe had 15 million consumers who turned to them to learn more about their ancestry and understand their disposition to diseases.

Regeneron agreed to acquire 23andMe for $256 million. At its peak, 23andMe's market value swelled to $5.8 billion. Recently, ...

If it gets a green light, as expected, the company could gain access to genetic data from more than 15 million 23andMe customers worldwide. Is Regeneron a good stock to buy now in light of a ...

Anne Wojcicki's last stand for 23andMe? The cofounder and former CEO plans to object to its sale to Regeneron through a ...

Biotech Regeneron already faces enough of its own challenges without taking on a the troubled legacy of ... Regeneron Is Buying 23andMe. The Deal Is a Head-Scratcher. By Josh Nathan-Kazis Share ...

Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Grill season is heating up, and for most Americans, cookouts are the crown jewel of an array of summer activities.Whether ...

Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data in response to privacy concerns sparked by ...

Congressman Glenn Ivey's trip to El Salvador took a strange turn when he was denied access to the "Maryland Man" who remains ...

Braskem is considering expanding its ethylene cracker and polyethylene complex in the Brazilian state of Rio de Janeiro by ...